
Pulmatrix PULM
€ 1.86
1.42%
Geschäftsbericht 2025
hinzugefügt 26.02.2026
Pulmatrix P/CF 2011-2026 | PULM
P/CF Jährlich Pulmatrix
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2 | -1.01 | -400 | -559 | -0.849 | -3.75 K | 9.23 | -0.44 | -2.56 | -2.87 | -2.92 | -4.7 | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 9.23 | -3.75 K | -393 |
P/CF anderer Aktien in der Pharmaeinzelhändler
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-0.654 | - | 2.43 % | $ 254 M | ||
|
AbCellera Biologics
ABCL
|
-7.33 | $ 3.56 | 2.01 % | $ 1.06 B | ||
|
Acorda Therapeutics
ACOR
|
-1.2 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
-2.73 | - | 4.01 % | $ 150 M | ||
|
Advaxis
ADXS
|
-0.0633 | - | -9.65 % | $ 45.9 M | ||
|
I-Mab
IMAB
|
-0.266 | - | - | $ 866 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-4.6 | - | - | $ 1.01 B | ||
|
AgeX Therapeutics
AGE
|
-0.0018 | - | -10.17 % | $ 12.2 K | ||
|
Aptorum Group Limited
APM
|
-3.44 | $ 0.79 | -0.79 % | $ 4.31 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
11.6 | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
-23.1 | - | -13.47 % | $ 169 M | ||
|
Albireo Pharma
ALBO
|
-5 | - | -0.23 % | $ 916 M | ||
|
Aileron Therapeutics
ALRN
|
-1.71 | - | 10.36 % | $ 9.8 M | ||
|
argenx SE
ARGX
|
-22.7 | $ 703.3 | 0.41 % | $ 25 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.88 | - | -1.52 % | $ 24.7 M | ||
|
Ascendis Pharma A/S
ASND
|
-17.6 | $ 231.03 | 2.23 % | $ 5 B | ||
|
ADC Therapeutics SA
ADCT
|
-5.23 | $ 4.22 | 2.18 % | $ 105 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-94.9 | $ 3.61 | 0.28 % | $ 8.69 B | ||
|
Midatech Pharma plc
MTP
|
-13.2 | - | -18.52 % | $ 27.3 M | ||
|
Adverum Biotechnologies
ADVM
|
-0.826 | - | - | $ 86.2 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-0.64 | - | - | $ 26.5 M | ||
|
Applied Molecular Transport
AMTI
|
-0.236 | - | - | $ 10.1 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
-2.92 | $ 6.63 | -0.75 % | $ 182 M | ||
|
Институт стволовых клеток человека
ISKJ
|
-89 | - | - | - | ||
|
Akero Therapeutics
AKRO
|
-14.1 | - | - | $ 3.67 B | ||
|
Athersys
ATHX
|
-5.78 | - | 3.77 % | $ 22.4 M | ||
|
Akouos
AKUS
|
-2.7 | - | 0.23 % | $ 488 M | ||
|
Acer Therapeutics
ACER
|
-0.401 | - | 2.71 % | $ 14 M | ||
|
ARCA biopharma
ABIO
|
-8.36 | - | 1052.0 % | $ 415 M | ||
|
Allena Pharmaceuticals
ALNA
|
-2.48 | - | 3.16 % | $ 1.9 M | ||
|
Aeterna Zentaris
AEZS
|
-4.82 | - | 5.93 % | $ 314 M | ||
|
AlloVir
ALVR
|
-0.723 | - | 4.14 % | $ 49.1 M | ||
|
Anika Therapeutics
ANIK
|
-209 | $ 14.36 | 1.13 % | $ 210 M | ||
|
Aptinyx
APTX
|
-0.159 | - | -39.0 % | $ 4.57 M | ||
|
BioNTech SE
BNTX
|
70.7 | $ 90.54 | -0.71 % | $ 27.2 B | ||
|
Aptose Biosciences
APTO
|
-0.0645 | - | -45.71 % | $ 1.2 M | ||
|
Burford Capital Limited
BUR
|
11.6 | $ 8.05 | 1.64 % | $ 1.31 B | ||
|
AVEO Pharmaceuticals
AVEO
|
-1.71 | - | - | $ 521 M | ||
|
Atea Pharmaceuticals
AVIR
|
-3.23 | $ 6.05 | -0.82 % | $ 493 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-0.224 | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
-8.14 | $ 2.64 | 3.94 % | $ 16.6 M | ||
|
Avenue Therapeutics
ATXI
|
-0.0603 | - | -52.27 % | $ 4.45 M | ||
|
BioCardia
BCDA
|
-0.892 | $ 1.27 | 0.79 % | $ 26.9 M | ||
|
Autolus Therapeutics plc
AUTL
|
-2.05 | $ 1.51 | 4.86 % | $ 385 M | ||
|
Athira Pharma
ATHA
|
-0.166 | - | - | $ 269 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-413 | $ 3.58 | -0.56 % | $ 7.79 B | ||
|
CureVac N.V.
CVAC
|
-4.82 | - | - | $ 867 M | ||
|
Aravive
ARAV
|
-0.928 | - | -13.39 % | $ 1.45 M | ||
|
AstraZeneca PLC
AZN
|
13.6 | - | - | $ 96.9 B | ||
|
Actinium Pharmaceuticals
ATNM
|
-1.46 | $ 1.11 | - | $ 33.4 M |